Table 1.
Antibody variant | KD (nM) | ka (M−1.s−1) | kd (s−1) | Neutralization IC50 (µg/ml) |
---|---|---|---|---|
m396 parental | nd | nd | nd | nd |
m396-C4 | 13.0 | 8.13 x 104 | 1.06 x 10−3 | 0.34 |
m396-B10 | 7.1 | 1.01 x 105 | 7.18 x 10−4 | 0.16 |
CR3022 parental | 99.2 | 7.19 x 104 | 7.13 x 10−3 | nd |
CR3022-B11 | 131.0 | 1.02 x 105 | 1.33 x 10−2 | nd |
CR3022-G11 | 93.6 | 2.41 x 105 | 2.26 x 10−2 | nd |
CR3022-B6 | 261.0 | 7.62 x 104 | 1.99 x 10−2 | 4.43 |
CR3022-M | 188.0 | 7.94 x 104 | 1.49 x 10−2 | 0.35 |
80R parental | nd | nd | nd | nd |
80R-A2 | 61.0 | 6.58 x 104 | 4.01 x 10−3 | 17.83 |
CR3014 parental | nd | nd | nd | nd |
CR3014-D1 | 50.8 | 7.95 x 104 | 4.04 x 10−3 | >100 |
CR3014-C8 | 61.1 | 5.84 x 104 | 3.57 x 10−3 | nd |
nd: no binding/neutralization detected